BRCA1 and breast cancer: Notably, 27% of aggressive molecular biological subtypes of breast cancer (Luminal B and triple-negative) were identified at stage I in Group A1, and the most common BRCA1 variant was c.5266dupC (rs80357906), accounting for 64.3% of such patients.